Unknown

Dataset Information

0

Magnetic Iron Nanocubes Effectively Capture Epithelial and Mesenchymal Cancer Cells.


ABSTRACT: Current methods for capturing circulating tumor cells (CTCs) are based on the overexpression of cytokeratin (CK) or epithelial cell-adhesion molecule (EpCAM) on cancer cells. However, during the process of metastasis, tumor cells undergo epithelial-to-mesenchymal transition (EMT) that can lead to the loss of CK/EpCAM expression. Therefore, it is vital to develop a capturing technique independent of CK/EpCAM expression on the cancer cell. To develop this technique, it is important to identify common secondary oncogenic markers overexpressed on tumor cells before and after EMT. We analyzed the biomarker expression levels in tumor cells, before and after EMT, and found two common proteins-human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) whose levels remained unaffected. So, we synthesized immunomagnetic iron nanocubes covalently conjugated with antibodies of Her2 or EGFR to capture cancer cells irrespective of the EMT status. The nanocubes showed high specificity (6-9-fold) in isolating the cancer cells of interest from a mixture of cells spiked in serum. We characterized the captured cells for identifying their EMT status. Thus, we believe the results presented here would help in the development of novel strategies for capturing both primary and metastatic cancer cells from patients' blood to develop an effective treatment plan.

SUBMITTER: Suresh D 

PROVIDER: S-EPMC7513327 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Magnetic Iron Nanocubes Effectively Capture Epithelial and Mesenchymal Cancer Cells.

Suresh Dhananjay D   Ghoshdastidar Shreya S   Gangula Abilash A   Mukherjee Soumavo S   Upendran Anandhi A   Kannan Raghuraman R  

ACS omega 20200909 37


Current methods for capturing circulating tumor cells (CTCs) are based on the overexpression of cytokeratin (CK) or epithelial cell-adhesion molecule (EpCAM) on cancer cells. However, during the process of metastasis, tumor cells undergo epithelial-to-mesenchymal transition (EMT) that can lead to the loss of CK/EpCAM expression. Therefore, it is vital to develop a capturing technique independent of CK/EpCAM expression on the cancer cell. To develop this technique, it is important to identify com  ...[more]

Similar Datasets

| S-EPMC5408164 | biostudies-literature
| S-EPMC6097834 | biostudies-literature
| S-EPMC5260876 | biostudies-literature
| S-EPMC4334736 | biostudies-literature
| S-EPMC6795213 | biostudies-literature
| S-EPMC6376448 | biostudies-literature
| S-EPMC3410962 | biostudies-literature
| S-EPMC6057462 | biostudies-literature
| S-EPMC5362815 | biostudies-literature
| S-EPMC7657182 | biostudies-literature